Pfizer Profits Plummet 52 Percent in Third Quarter

Drug Industry Daily
KEYWORDS Markets / Patents
A A

Pfizer’s profits fell a staggering 52 percent during the third quarter compared to a year earlier, the company said Oct. 20, due to several factors including lower drug sales, increased generic competition and acquisition costs.

To View This Article:

Login

Subscribe To Drug Industry Daily